Atara Biotherapeutics Inc (ATRA) stock forecast · rev $1.1M
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
This ATRA forecast page states what the cached financials imply — not a price target and not a guarantee. Atara Biotherapeutics Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.
Period-over-period revenue change is not in cache for ATRA, so this page does not invent a growth rate.
ATRA currently screens at market cap $87.1M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ATRA 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ATRA stock page.
Not investment advice.